References
- Vinci J. M., Horwitz D., Zusman R. M., Pisano J. J., Catt K. J., Keiser A. R. The effect of converting enzyme inhibition with SQ 20881 on plasma and urinari kinins, prostaglandin E, and angiotensin II in hypertensive man. Hypertension 1979; 1: 416–26
- Mc Caa R. E., Hall J. E., Mc Caa C. S. The effects of angiotensin converting enzyme inhibitors on arterial blood pressure and urinary sodium excretion role of the renin-angio tensin and kallikrein-kinin systems. Circ Res 1978; 43(suppl I)32–9
- Carretero O. A., Scicli A. G. Possible role of kinins in circulatory homeostasis. Hypertension 1981; 3(suppl I)4–12
- Overlack O., Stumpe K. O., Kuhnert M., Heck J. Altered blood pressure and renin responses to converting enzyme inhibition after aprotinininduced kallikrein-kinin system blockade. Clin Sci 1980; 59(supp1)129–32
- Madeddu P., Dessi'-Fulgheri P., Oppes M., Rubattu S., Bandiera F., Tonolo G. C., Troffa C. M., Soro A., Glorioso, Rappelli A. A blunted activation of prekallikrein in essential and renovascular hypertension with low urinary active kallikrein excretion. “Renovascular Hypertension”, N. Glorioso, J. H. Laragh, A. Rappelli. Raven press, New York 1986; 61–74
- Amundsen E., Putter J., Friberger P., Knos M., Larsbroten M., Claeson G. Methods for determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol 1979; 120A: 83–95
- Carretero O. A., Scicli A. G. The renal kallikrein system. Am J Physiol 1980; 238: F247–55
- Margolius H. S., Horwitz D., Pisano J. J. Urinary kallikrein excretion in normal men. Relationship to sodium intake and sodium retaining steroids. Circ Res 1974; 35: 820–25
- Karlberg B. E., Ohmon K. P., Nilsson O. R., Wettre S. Captopril lowers urinary kallikrein in hypertensive patients. Lancet 1980; 1: 150
- Marin-Grez M., Bonner G., Gross F. Captopril, kallikrein and hypertension. Lancet 1980; I: 1033